Clinical Trial Update: Letrozole for Lymphangioleiomyomatosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for letrozole in lymphangioleiomyomatosis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphangioleiomyomatosis

Drugs mentioned

• Letrozole (letrozole)

Snippet

Sponsor: University of Cincinnati | Conditions: Lymphangioleiomyomatosis | Phase 2 | Status: COMPLETED | Results posted: 2024-04-17